Alembic Pharmaceuticals Ltd (APLLTD) — Announcement | 16 September 2026
Alembic Pharmaceuticals announced that the USFDA closed its inspection of the Vadodara bioequivalence facility conducted from March 3-7, 2025, issuing an Establishment Inspection Report and requesting exchanges to record the update, marking a key regulatory milestone for its US market operations.
About Alembic Pharmaceuticals Ltd (APLLTD)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when APLLTD files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track APLLTD — Free💡 Ask AI about this filing
📊 More APLLTD filings
- Announcement — 28 September 2026Alembic Pharmaceuticals announced that its trading window will close on October 1, 2026, and remain ...
- 🔴 Announcement — 18 September 2026Alembic Pharmaceuticals announced one-to-one investor and analyst meetings in Mumbai on September 23...
- 🔴 Announcement — 11 September 2026Alembic Pharmaceuticals announced the successful completion of an unannounced USFDA onsite bioequiva...
- 🔴 Announcement — 7 September 2026Alembic Pharmaceuticals announced the incorporation of its wholly owned subsidiary, Alembic Pharmace...
- 🔴 Announcement — 27 August 2026Alembic Pharmaceuticals announced a series of one-on-one investor and analyst meetings scheduled for...
🔥 Also filed on 16 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when APLLTD files new disclosures
Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track APLLTD — FreeFree account · 2 AI queries/day